Ischemix's Unattributed Round

Ischemix raised a round of funding on June 05, 2014.

Ischemix is a privately-held, clinical-phase biotechnology company developing a portfolio of therapeutic compounds for the prevention and treatment of serious cardio-renal conditions. The Company's le…

Articles about Ischemix's Unattributed Round: